PEGULICIANINE ACETATE
UNII F3F6208UMT

Substance Identification & Data

This profile provides standardized clinical and technical data for Pegulicianine Acetate, uniquely identified by the FDA Unique Ingredient Identifier (UNII) F3F6208UMT.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2230217-18-0 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

F3F6208UMT

CAS Registry Number

2230217-18-0

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

PEGULICIANINE ACETATE

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C175839

National Cancer Institute reference terminology for clinical and research data.

USAN ID

GH-99

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Pegulicianine Acetate. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

PEGULICIANINE ACETATE

Common Names & Synonyms

PEGULICIANINE ACETATE [USAN]

PEGULICIANINE ACETATE [WHO-DD]

Brand / Trade Names

LUMICELL

LUMISIGHT

Systematic Nomenclature

N-(6-(((1-((2-((Z)-3,6-BIS(2,3-DIHYDRO-1H-INDOL-1-YL)XANTHYLIUM-9-YL)PHENYL)SULFONYL)PIPERIDIN-4-YL)CARBONYL)AMINO)HEXANOYL)GLYCYLGLYCYL-L-ARGINYL-N6-(6-(2-(5-(1-ETHYL-1,3-DIHYDRO-3,3-DIMETHYL-5-SULFO-2H-INDOL-2-YLIDENE)PENTA-1,3-DIEN-1-YL)-3,3-DIMETHYL-5-SULFO-3H-INDOLIO)-1-OXOHEXYL)-L-LYSYL-(2-(2-AMINOETHOXY)ETHOXY)ACETYL-S-((3RS)-1-(6-(.ALPHA.-METHYLPOLY(OXYETHYLENE)AMINO)-6-OXOHEXYL)-2,5-DIOXOPYRROLIDIN-3-YL)-L-CYSTEINAMIDE BIS(INNER SALT), ACETATE (1:1)

SYS

POLY(OXY-1,2-ETHANEDIYL), .ALPHA.-METHYL-.OMEGA.-HYDROXY-, 6-ETHER WITH N-(6-(((1-((2-(3,6-BIS(2,3-DIHYDRO-1H-INDOL-1-YL)XANTHYLIUM-9-YL)PHENYL)SULFONYL)-4-PIPERIDINYL)CARBONYL)AMINO)-1-OXOHEXYL)GLYCYLGLYCYL-L-ARGINYL-N6-(6-(2-(5-(1-ETHYL-1,3-DIHYDRO-3,3-DIMETHYL-5-SULFO-2H-INDOL-2-YLIDENE)-1,3-PENTADIEN-1-YL)-3,3-DIMETHYL-5-SULFO-3H-INDOLIO)-1-OXOHEXYL)-L-LYSYL-2-(2-(2-AMINOETHOXY)ETHOXY)ACETYL-S-(1-(6-((2-HYDROXYETHYL)AMINO)-6-OXOHEXYL)-2,5-DIOXO-3-PYRROLIDINYL)-L-CYSTEINAMIDE BIS(INNER SALT), ACETATE (1:1)

SYS